Owls Nest Partners discloses new $20M CorVel stake in contrarian Q1 2026 bet
What's the deal? Investment firm Owls Nest Partners disclosed a new $20.06M position in CorVelDealroom has a profile for this one. Try Dealroom → (NASDAQ: CRVL), acquiring 348,329 shares during Q1 2026. The 13F filing, dated 14 May 2026, represents 6.66% of the firm's reportable assets under management and a 7.02% increase in its total 13F portfolio.
CorVelDealroom has a profile for this one. Try Dealroom → provides technology-driven workers' compensation, auto, liability, and health solutions — using AI and machine learning to manage healthcare claims and contain medical costs. It serves employers, insurers, third-party administrators, and government agencies.
Why now? The bet looks squarely contrarian. CorVel shares were trading at $62.74 in mid-May 2026, down 45% over the trailing twelve months — dramatically underperforming the S&P 500, which gained about 28% over the same span.
But the company's fundamentals tell a different story. Fiscal 2026 revenue climbed 7% to $959M, diluted earnings per share jumped 17% to $2.14, and CorVel ended the year with $233M in cash and no debt. Management flagged growing demand for CERIS, its healthcare payment accuracy platform, with several large payer wins expected to boost revenue visibility as deployments scale.
The company also pointed to continued investment in AI, automation, telemedicine, cybersecurity, and data integration across its claims management business.
What could go wrong? A 45% drop in a single fiscal year suggests the market sees risks that earnings alone don't capture. CorVel operates in a competitive insurance services landscape where client concentration, regulatory shifts, and pricing pressure could weigh on margins. And while the fundamentals look solid, a contrarian bet only pays off if the market eventually agrees — which is never guaranteed.
The position also represents a meaningful chunk of Owls Nest's portfolio at nearly 7% of assets, amplifying the impact if the thesis doesn't play out.
The signal: Owls Nest's concentrated bet — nearly 7% of its portfolio in a single new position — underscores a growing appetite among active managers for cash-rich, debt-free businesses trading at steep discounts to 52-week highs, particularly those embedding AI into large, slow-moving verticals like insurance claims management. With CorVel's revenue growing at 7% and EPS up 17% even as the stock halved, the divergence between operational performance and market sentiment is exactly the kind of dislocation that draws contrarian capital.
Read more: theglobeandmail.com
